A Case Report of a patient with aRare and Aggressive Plasma

Cell Leukemiaby Siprianus Ugroseno Yudho Bintoro

Submission date: 05-Jul-2020 12:28AM (UTC+0800)Submission ID: 1353393168File name: of_a_patient_with_a_Rare_and_Aggressive_Plasma_Cell_Leukemia.pdf (266.68K)Word count: 2267Character count: 12570

25%SIMILARITY INDEX

13%INTERNET SOURCES

24%PUBLICATIONS

0%STUDENT PAPERS

1 1%

2 1%

3 1%

4 1%

5 1%

6 1%

A Case Report of a patient with a Rare and Aggressive PlasmaCell LeukemiaORIGINALITY REPORT

PRIMARY SOURCES

Jelinek, Tomas, Fedor Kryukov, Lucie Rihova,and Roman Hajek. "Plasma cell leukemia: frombiology to treatment", European Journal OfHaematology, 2015.Publication

"Hematopathology in Oncology", SpringerScience and Business Media LLC, 2004Publication

docplayer.netInternet Source

jco.ascopubs.orgInternet Source

www.em-consulte.comInternet Source

Suzanne R. Hayman. "Plasma cell leukemia",Current Treatment Options in Oncology,06/2001Publication

7 1%

8 1%

9 1%

10 1%

11 1%

12 1%

13 1%

14 1%

"Multiple Myeloma and Other Plasma CellNeoplasms", Springer Science and BusinessMedia LLC, 2018Publication

link.springer.comInternet Source

eprints.umm.ac.idInternet Source

Marta Lionetti, Antonino Neri. "Utilizing next-generation sequencing in the management ofmultiple myeloma", Expert Review of MolecularDiagnostics, 2017Publication

www.ina-jghe.comInternet Source

www.omicsonline.orgInternet Source

"Neoplastic Diseases of the Blood", SpringerScience and Business Media LLC, 2018Publication

Régis Costello, Daniele Sainty, RedaBouabdallah, Jean-Pierre Fermand et al."Primary plasma cell leukaemia: a report of 18cases", Leukemia Research, 2001Publication

15 1%

16 1%

17 1%

18 1%

19 1%

20 1%

21 1%

22 1%

23 1%

Katodritou, E.. "Response of primary plasma cellleukemia to the combination of bortezomib anddexamethasone: Do specific cytogenetic andimmunophenotypic characteristics influencetreatment outcome?", Leukemia Research,200807Publication

Handbook of Multiple Myeloma, 2015.Publication

ijmsph.comInternet Source

Paul Mellor. "Plasma Cell Disorders", ElsevierBV, 2016Publication

www.journalagent.comInternet Source

ascopubs.orgInternet Source

www.mdpi.comInternet Source

findresearcher.sdu.dkInternet Source

Hong Chang, Xiaoying Qi, Joanna Yeung,Donna Reece, Wei Xu, Bruce Patterson."Genetic aberrations including chromosome 1

24 1%

25 <1%

26 <1%

27 <1%

abnormalities and clinical features of plasma cellleukemia", Leukemia Research, 2009Publication

Chandan Kumar, Garima Jain, Abhenil Mittal,Lalit Kumar, Anita Chopra. "Primary plasma cellleukaemia in a 20-year young adult male: a rarepresentation", Journal of Hematopathology,2019Publication

Daniel Lebovic, Ling Zhang, Melissa Alsina,Taiga Nishihori et al. "Clinical Outcomes ofPatients With Plasma Cell Leukemia in the Eraof Novel Therapies and Hematopoietic StemCell Transplantation Strategies: A Single-Institution Experience", Clinical LymphomaMyeloma and Leukemia, 2011Publication

Steven Saccaro. "Primary plasma cell leukemia:Report of 17 new cases treated with autologousor allogeneic stem-cell transplantation andreview of the literature", American Journal ofHematology, 04/2005Publication

Jimenez-Zepeda, Victor H., Donna E. Reece,Suzanne Trudel, Christine Chen, RodgerTiedemann, and Vishal Kukreti. "Lenalidomide(Revlimid), bortezomib (Velcade) and

28 <1%

29 <1%

30 <1%

dexamethasone for the treatment of secondaryplasma cell leukemia", Leukemia & Lymphoma,2015.Publication

J. Tedesco. "High prevalence of obesity in acutepromyelocytic leukemia (APL): implications fordifferentiating agents in APL and metabolicsyndrome", Therapeutic Advances inHematology, 06/01/2011Publication

Katodritou, Eirini, Evangelos Terpos, CharikleiaKelaidi, Maria Kotsopoulou, Sossana Delimpasi,Marie-Christine Kyrtsonis, Argiris Symeonidis,Nikos Giannakoulas, Aikaterini Stefanoudaki,Dimitrios Christoulas, Christina Chatziaggelidou,Vassiliki Gastari, Nikos Spyridis, EvgeniaVerrou, Pavlina Konstantinidou, Kostas Zervas,and Meletios A. Dimopoulos. "Treatment withbortezomib-based regimens improves overallresponse and predicts for survival in patientswith primary or secondary plasma cell leukemia:Analysis of the Greek Myeloma study group :Bortezomib for Plasma-Cell Leukemia",American Journal of Hematology, 2013.Publication

Tengteng Yu, Yan Xu, Gang An, Yu-Tzu Tai etal. "Primary Plasma Cell Leukemia: A Real-World Retrospective Study of 46 Patients from a

31 <1%

32 <1%

33 <1%

34 <1%

35 <1%

36 <1%

Single Center Study in China", ClinicalLymphoma Myeloma and Leukemia, 2020Publication

Naeim, Faramarz, P. Nagesh Rao, Sophie X.Song, and Wayne W. Grody. "Plasma CellNeoplasms", Atlas of Hematopathology, 2013.Publication

Ridvan Ali, Meral Beksac, Fahir Ozkalemkas,Vildan Ozkocaman, Atilla Ozkan, Tulay Ozcelik,Ahmet Tunali. "Efficacy of bortezomib incombination chemotherapy on secondaryplasma cell leukemia", Leukemia & Lymphoma,2009Publication

"Abstracts", Hepatology International, 2020Publication

Nandita Majumdar, Rajive Kumar, Mona Anand,Dipti Kalita et al. "Plasma cell leukemia – astudy of 28 cases from India", Hematology,2013Publication

Michaela Liedtke, Bruno C Medeiros. "Plasmacell leukemia: concepts and management",Expert Review of Hematology, 2014Publication

Neoplastic Diseases of the Blood, 2013.Publication

37 <1%

38 <1%

Exclude quotes On

Exclude bibliography On

Exclude matches Off

Sung-Hoon Jung, Je-Jung Lee, Kihyun Kim,Cheolwon Suh et al. "The role of frontlineautologous stem cell transplantation for primaryplasma cell leukemia: a retrospectivemulticenter study (KMM160)", Oncotarget, 2017Publication

"Biology and Management of Unusual PlasmaCell Dyscrasias", Springer Science andBusiness Media LLC, 2017Publication

FINAL GRADE

/100

A Case Report of a patient with a Rare and Aggressive PlasmaCell LeukemiaGRADEMARK REPORT

GENERAL COMMENTS

Instructor

PAGE 1

PAGE 2

PAGE 3

PAGE 4

PAGE 5